Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4791
Source ID: NCT03111238
Associated Drug: Rex-001
Title: The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Peripheral Arterial Disease (PAD)|Diabetes Mellitus (DM)|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Cardiovascular Disease|Critical Limb Ischemia (CLI)
Interventions: DRUG: REX-001|DRUG: Placebo
Outcome Measures: Primary: Complete relief of ischemic rest pain without developing ischemic lesions on the index leg., Change in Rutherford classification from CLI Category 4 to Category 3 or lower 12 months after administration of REX-001 or placebo., The primary endpoint for this trial will be assessed at 12 months. |
Sponsor/Collaborators: Sponsor: Ixaka Ltd | Collaborators: Andalusian Network for Design and Translation of Advanced Therapies
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 3
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2017-04-05
Completion Date: 2021-03-31
Results First Posted:
Last Update Posted: 2021-05-07
Locations: Fakultní nemocnice Ostrava, Ostrava, Czechia|Vitkovicka nemocnice a. s. Vaskularni centrum, Ostrava, Czechia|Klinikum der Goethe-Universität Frankfurt, Frankfurt, Germany|Pécsi Tudományegyetem, PTE-KK I. sz Belgyógyászati Klinika, Pécs, Hungary|Instytut Hematologii i Transfuzjologii, Warsaw, Poland|Centro Hospitalar de São João, Porto, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario Puerta del Mar, Cadiz, Spain|First site: Hospital Universitario Reina Sofía, Córdoba, Spain|Complejo Hospitalario Universitario de Granada, Hospital del Campus de la Salud, Granada, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Universitario Virgen de Valme, Sevilla, Spain
URL: https://clinicaltrials.gov/show/NCT03111238